LuxEtVeritas
Bluelighter
a friend has late stage breast cancer and i want to look into this further:
Cancer Research 67, 3337-3344, April 1, 2007. doi: 10.1158/0008-5472.CAN-06-2480
© 2007 American Association for Cancer Research
Experimental Therapeutics, Molecular Targets, and Chemical Biology
A Peptide Conjugate of Vitamin E Succinate Targets Breast Cancer Cells with High ErbB2 Expression
OR...
perhaps would it be simpler and possibly as effective to use just higher dose a-TOS
http://clincancerres.aacrjournals.org/cgi/content/abstract/8/3/863
(full text is free to note here)
and
http://molpharm.aspetjournals.org/cgi/content/abstract/71/5/1185
also as to Mitocans I wonder if there is a MitoQ counterpart since it relate to mitochondrial targeting...hmmmmm.
Cancer Research 67, 3337-3344, April 1, 2007. doi: 10.1158/0008-5472.CAN-06-2480
© 2007 American Association for Cancer Research
Experimental Therapeutics, Molecular Targets, and Chemical Biology
A Peptide Conjugate of Vitamin E Succinate Targets Breast Cancer Cells with High ErbB2 Expression
OR...
perhaps would it be simpler and possibly as effective to use just higher dose a-TOS
http://clincancerres.aacrjournals.org/cgi/content/abstract/8/3/863
(full text is free to note here)
and
http://molpharm.aspetjournals.org/cgi/content/abstract/71/5/1185
also as to Mitocans I wonder if there is a MitoQ counterpart since it relate to mitochondrial targeting...hmmmmm.

